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Desflurane allows for a faster 
emergence when compared to 
sevoflurane without affecting the 
baseline cognitive recovery time
Joseph G. Werner1 , Karina Castellon-Larios1* , Cattleya Thongrong1 , Bodo E. Knudsen2 , 
Deborah S. Lowery1 , Maria A. Antor1 and Sergio Daniel Bergese1
1 Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA, 2 Department of 
Urology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
aims: We compared the effect of desflurane and sevoflurane on anesthesia recovery 
time in patients undergoing urological cystoscopic surgery. The Short Orientation-
Memory-Concentration Test (SOMCT) measured and compared cognitive impairment 
between groups and coughing was assessed throughout the anesthetic.
Methods and materials: This investigation included 75 ambulatory patients. Patients 
were randomized to receive either desflurane or sevoflurane. Inhalational anesthetics 
were discontinued after removal of the cystoscope and once repositioning of the patient 
was final. Coughing assessment and awakening time from anesthesia were assessed 
by a blinded observer.
statistical analysis used: Statistical analysis was performed by using t-test for para-
metric variables and Mann–Whitney U test for non-parametric variables.
results: The primary endpoint, mean time to eye-opening, was 5.0 ± 2.5 min for desflu-
rane and 7.9 ± 4.1 min for sevoflurane (p < 0.001). There were no significant differences 
in time to SOMCT recovery (p = 0.109), overall time spent in the post-anesthesia care 
unit (PACU) (p = 0.924) or time to discharge (p = 0.363). Median time until readiness for 
discharge was 9 min in the desflurane group, while the sevoflurane group had a median 
time of 20 min (p = 0.020). The overall incidence of coughing during the perioperative 
period was significantly higher in the desflurane (p = 0.030).
conclusion: We re-confirmed that patients receiving desflurane had a faster emergence 
and met the criteria to be discharged from the PACU earlier. No difference was found in 
time to return to baseline cognition between desflurane and sevoflurane.
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inTrODUcTiOn
Desflurane and sevoflurane are the two most commonly 
administered inhaled anesthetics for outpatient surgeries due to 
their favorable pharmacokinetic profiles and low incidence of 
untoward effects. Both of these agents have been safely used for 
anesthesia maintenance using a laryngeal mask airway (LMA) 
(1–4). Multiple studies have demonstrated that desflurane allows 
for a more rapid emergence than sevoflurane, and this may be 
beneficial for outpatient surgery, where quick case turnover and 
reduced post-anesthesia care unit (PACU) time is essential to 
ensure a good workflow (2, 3).
Our primary objective was to compare the effect of desflurane 
and sevoflurane on anesthesia recovery time in patients under-
going urological cystoscopic surgery under general anesthesia 
using a LMA. Given the recent interest in post-operative cogni-
tive dysfunction, as a secondary objective, we employed a more 
robust test of cognitive function to see if there was a difference 
in recovery of cognitive function between the two inhalational 
anesthetic, using the Short Orientation-Memory-Concentration 
Test (SOMCT) (Supplementary Material) (5, 6). Additionally, 
we measured the presence of coughing, during the period from 
induction to return of spontaneous respiration. In order to 
accomplish this, we modified our anesthesia protocol to maintain 
stable end-tidal anesthetic concentrations and administer intra-
venous (IV) fentanyl on induction.
MaTerials anD MeThODs
We conducted a single center, prospective, randomized clinical 
trial after obtaining Institutional Review Board approval and being 
registered in clinicaltrials.gov under the identifier NCT01219881.
The investigation was conducted between September 2010 and 
October 2012 on 75 ambulatory patients ages 50–75, ASA I to III, 
and undergoing urological cystoscopic surgery under general anes-
thesia with a LMA. After patients signed consent, they were rand-
omized via a computer-generated list to receive either desflurane or 
sevoflurane for induction and maintenance of anesthesia. Principal 
investigator and co-investigators were able to enroll patients into 
the study. The exclusion criteria included history of allergy, intoler-
ance, or contraindications to any study medication, alcohol or drug 
abuse within 1 year, body mass index >35kg/m2, history of hiatal 
hernia, gastroesophageal reflux disease, or pharyngeal pathology, 
and a diagnosis of decreased pulmonary compliance.
Demographics, detailed medical history, current medications, 
and baseline vitals were collected from each patient. Prior to 
entering the operating room, each patient was asked to complete a 
baseline 11-point verbal rating questionnaire for pain and nausea.
After premedication with 0.5–2  mg IV midazolam, patients 
were preoxygenated using spontaneous mask ventilation at 100% 
O2 and a fresh gas flow of 6 L/min of oxygen for 1–4 min prior 
to induction. Anesthesia induction was performed via IV bolus 
injections of 2  mg/kg propofol and 1–2  μg/kg fentanyl. After 
induction, the inhaled anesthetic vaporizer was opened to 1 mini-
mum alveolar concentration (MAC), i.e., 5.4–7.4 volume% for 
desflurane and 1.4–2.5 volume% for sevoflurane, based on study 
randomization for 1–2 min using mask ventilation with inhaled 
anesthetic; following, the fresh gas inflow was turned off, and a 
lubricated LMA was inserted. After placing a seal around it, and 
measuring for tidal volume leak, the fresh gas inflow was imme-
diately restored to 4–6 L/min of 100% oxygen with the vaporizer 
set at 1 MAC for 3 min. The patient was placed on volume or 
pressure-control mechanical ventilation until spontaneous res-
piratory efforts were made and spontaneous breathing without 
support was achieved. For the duration of the case, desflurane or 
sevoflurane was maintained between 0.5 and 1 MAC, inspired 
in a 50:50 air/oxygen mixture at a total gas flow rate of 1 L/min.
In addition to American Society of Anesthesiologists-
recommended standard monitoring, we used continuous 
registration of bispectral index (BIS) in all patients. The hemo-
dynamic, oxygen saturation and BIS values were recorded before 
induction of anesthesia and every 5  min throughout surgery. 
IV fluids, additional boluses of fentanyl, lidocaine, propofol, or 
vasopressors, were administered as needed to maintain analgesia 
and hemodynamics within 20% of baseline. Opioid medication 
was also used according to anesthesiologist discretion. IV hydro-
morphone or morphine was used. These were then transformed 
to morphine equivalents later on for the purpose of this study.
Each episode of coughing from induction of anesthesia 
through removal of LMA was recorded by a blinded observer and 
graded according to a standardized scale (2). Coughing was char-
acterized as 0 = no coughing; 1 = single cough and SpO2 ≥ 95%; 
2 =  multiple coughs occurred and SpO2 ≥  95%; 3 =  multiple 
coughs occurred and SpO2 < 95%; 4 = multiple coughs occurred, 
SpO2 < 95%, and if coughing required administration of an IV 
medication.
At the end of procedure, the inhalational anesthetic was 
discontinued and the fresh gas flow was increased to 6–8 L/min 
of 100% oxygen. Discontinuation only occurred after removal of 
the cystoscope and once repositioning of the patient was final. In 
order to standardize the awakening, the only permissible stimulus 
was verbalization of the patient’s name and the command “open 
your eyes,” which was given at 1-min intervals while the LMA was 
still in place. The mask was removed once the patient displayed a 
purposeful response to the verbal stimuli. Coughing assessment 
and awakening time from anesthesia were assessed by a blinded, 
trained observer.
Post-anesthesia physical recovery status was evaluated 
according to the Aldrete score, assessed every 5 min after extu-
bation until the patients reached a score ≥9 (7). Thereafter, a 
blinded observer performed the SOMCT every 15 min to evalu-
ate post-operative cognitive function for the first hour after sur-
gery and at the time of discharge from the PACU (8). Procedure 
length, length of stay in the PACU, and time to discharge from 
the hospital were also recorded.
At 24 h after surgery, overall satisfaction about their experi-
ence with the anesthetic medication was assessed; either by 
personal interview or phone call conducted by blinded person-
nel. We assessed their subjective well-being while in the PACU, 
as well as their pain treatment and any intraoperative awareness. 
Satisfaction was rated using a 3-point rating scale: 2 =  highly 
satisfied, 1 = satisfied, and 0 = dissatisfied.
The sample size of 68 patients was need to reach an 80% 
power and to detect an intergroup difference of 3  min in the 
TaBle 3 | emergence and immediate recovery times after 
discontinuation of volatile anesthetics in the two study groups.
Durationa Desflurane sevoflurane p-Value
Time to eye-opening 
(extubation time)
5.0 ± 2.5 7.9 ± 4.1 <0.001*
Time until Aldrete ≥9 5 (0, 5) 5 (5, 5) 0.404
Time until SOMCT recovery 
(extubation time + return to 
SOMCT baseline)
15 (5, 30) 15 (5, 20) 0.109
Time until ready for discharge 
(extubation time + time until 
Aldrete ≥9)
9 (5, 18) 20 (9, 27) 0.020*
PACU length of stay 71.4 ± 31.6 71.7 ± 29.3 0.924
Floor length of stay 89 (75, 122) 115 (78, 130) 0.199
Time until discharge 141 (113, 189) 158 (130, 210) 0.363
PACU, post-anesthesia care unit; SOMCT, Short Orientation-Memory-Concentration 
Test.
Values are number (n), percentage (%), mean ± SD or median (range).
*p < 0.05 was considered statistically significant.
aDuration in minutes.
Bold font means statistically significant measurements between both groups.
TaBle 2 | anesthetic medications.
Medication dosage Desflurane sevoflurane p-Value
Midazolam (mg) 2 (2, 2) 2 (2, 2) 0.821
Fentanyl (μg) 100 (100, 100) 100 (75, 100) 0.628
Propofol (mg) 165 (140, 200) 150 (132, 179) 0.438
Lidocaine (mg) 100 (80, 100) 90 (60, 100) 0.280
Total opioid consumption (mg) 37 (30, 52) 42 (37, 65) 0.062
No significant differences were observed.
Data are presented as median [interquartile range (IQR)].
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time to eye-opening after surgery between the two treatment 
groups assuming group means are 5.0 and 8.0 with a SD of 3.0 
and 5.0, respectively. The sample size was calculated based on 
a two-sided, two-sample T test at the significance level of 0.05.
Computer software SAS 9.2 was used to conduct the statisti-
cal analysis. Initially, descriptive statistics were calculated for 
demographic data and presented as mean  ±  SD, median, or 
percentages. Statistical analysis was performed by using t-test 
for parametric variables and Mann–Whitney U test for non-
parametric variables. Additionally, chi-square and Fisher’s exact 
tests were used to analyze count data to investigate the relation-
ship between categorical variables. Log transformation has been 
performed whenever found to be appropriate (PACU length of 
stay and length of surgery) before the analysis. A p < 0.05 was 
considered statistically significant.
resUlTs
Seventy-five patients provided written consent for the study, 66 
(n = 34 desflurane group; n = 32 sevoflurane group) were able to 
successfully complete all the assessments. The primary reasons 
for screen failure were failure to meet all the inclusion/exclusion 
criteria (n = 3) and failure to correctly place the LMA (n = 4). 
There were two cases that were considered early termination and 
not included in the final analysis: one patient was converted to the 
prone position (intubated midway through the case); the other 
patient experienced a laryngospasm prior to case completion.
There were no significant differences in demographic param-
eters except pain at rest (Table  1). There were four subjects 
with pain at rest in the desflurane group (12%) versus 11 in the 
sevoflurane group (34%) (p = 0.028). No significant differences 
in anesthetic medications administered were observed between 
the two groups (Table 2).
TaBle 1 | Demographic data.
Desflurane 
(n = 34)
sevoflurane 
(n = 32)
p-Value
Age (years old) 61.1 ± 7.7 61.3 ± 6.6 0.899
Weight (kg) 83.3 ± 18.2 81.3 ± 16.6 0.646
Height (cm) 172.2 ± 10.7 170.4 ± 9.5 0.484
BMI (kg/m2) 27.8 ± 4.6 27.8 ± 4.5 0.952
Sex (male) (n, %) 20 (58%) 15 (46%) 0.331
ASA (n) I: 1 I: 0 0.070
II: 13 II: 16
III: 20 III: 16
History of smoking (yes) (n, %) 16 (47%) 10 (31%) 0.189
Baseline verbal rating scale 
scores (0–10) (n, %)
 Nausea (yes) 2 (6%) 3 (9%) 0.592
 Pain at rest (yes) 4 (12%) 11 (34%) 0.028a
Baseline SOMCT score 
(maximum 28) [median (IQR)]
24 (24, 26) 24 (24, 26) 0.939
Anesthesia time (min) 82.7 ± 15.0 85.9 ± 21.9 0.491
Surgery time (min) 45.0 ± 16.9 45.7 ± 17.0 0.829
aIndicates significant differences between two groups.
Data are presented as mean ± SD or number (percentage) unless otherwise noted.
Bold font means statistically significant measurements between both groups.
Results from the recovery endpoints are presented in Table 3. 
The mean time to eye-opening was 5.0 ± 2.5 min for desflurane 
and 7.9 ±  4.1  min for sevoflurane (p <  0.001). There were no 
significant differences in time to SOMCT recovery (p = 0.109), 
overall time spent in the PACU (p = 0.924), or time to discharge 
(p = 0.363). Median time until readiness for discharge was 9 min 
[mean of 5–18 min in the desflurane group, median of 20 min 
with mean of 9–27 min for the sevoflurane group (p = 0.02)].
The incidences of coughing during induction of anesthesia, 
intraoperatively, or at emergence from anesthesia were individually 
not significantly higher in patients receiving desflurane; however, 
the overall incidence of coughing during the perioperative period 
was significantly higher in the desflurane group compared to the 
sevoflurane group (p = 0.030; Table 4). The coughing episodes 
that occurred were short-lasting, did not lead to desaturation 
below 95%, or interrupt the surgical procedures. As mentioned 
earlier, one case of intraoperative laryngospasm occurred in the 
desflurane treatment arm. No significant difference was observed 
with regard to the anesthesia satisfaction endpoint (Table 5).
DiscUssiOn
Given the blood gas-partition coefficients for desflurane and 
sevoflurane, it is not surprising that patients that received desflu-
rane had quicker emergence from anesthesia, and the amount of 
time, roughly 3 min, is similar to that reported previously (4,  9). 
TaBle 5 | Patient satisfaction rate.
category sevoflurane (n = 24) Desflurane (n = 25) p-Value
Very satisfied 11 (45.8%) 11 (44.0%) 0.8839
Satisfied 12 (50.0%) 14 (56.0%)
Unsatisfied 1 (4.2%) 0 (0.0%)
Data were available for 24 and 25 patients in the sevoflurane and desflurane group, 
respectively.
Data are presented as number (percentage).
TaBle 4 | The incidence of coughing during the perioperative period.
coughing Desflurane sevoflurane p-Value
Intubation (n, %) 4 (12%) 1 (3) 0.197
Degree (n, %)
 0 30 (88%) 31 (97%) 0.356
 1 2 (6%) 1 (3%) 0.999
 2 2 (6%) 0 0.492
Extubation (n, %) 10 (30%) 4 (13%) 0.060
Degree (n, %)
 0 23 (70%) 27 (87%) 0.132
 1 4 (12%) 0 0.113
 2 6 (18%) 4 (13%) 0.733
Coughed during intubation 
and extubation (n, %)
2 (6%) 1 (3%) 0.392
Number of patients coughing 
perioperatively (n, %)
12 (35%) 4 (12%) 0.030*
Data are presented as number (percentage).
*p < 0.05 was considered statistically significant.
Bold font means statistically significant measurements between both groups.
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Furthermore, the time until the patients were ready for PACU 
discharge was also shorter by a median value of 11  min if the 
patient was administered desflurane. In a busy outpatient surgery 
center, the cumulative gain in time over 6–10 cases might encour-
age one to use desflurane for maintenance anesthesia for all the 
patients. However, the overall duration of PACU time did not dif-
fer between groups and our mean PACU length of stay of 71.4 and 
71.7 min was similar to the length of stay to the study by White 
et  al., which had mean times of 80 and 79  min for desflurane 
and sevoflurane, respectively. It is unlikely that this PACU length 
of stay could be shortened, especially in ambulatory surgery as 
it takes time for patients to display that they are “street ready” 
by being able to drink fluids without getting nauseated, tolerable 
pain levels, be able to ambulate, as well as have an Aldrete score 
≥9. The primary outcome of our study is consistent with previous 
studies that demonstrate a quicker emergence with desflurane, 
with no effect on PACU discharge (3, 4, 10).
The SOMCT is a six-item test that can be used to stratify 
cognitive deficits. It is a shortened test that correlates with the 
scores of a larger validated 26-item test (Blessed Information-
Memory-Concentration Test) and thus has the benefit of being 
able to stratify cognitive dysfunction yet short enough to be given 
multiple times to assess the duration of this cognitive impairment 
(8, 11). Although the SOMCT is validated in the elderly to help 
stratify dementia, it is also possible that it is not robust enough to 
detect early post-anesthetic cognitive impairment.
Bilotta et  al. (6) showed quicker cognitive recovery after 
desflurane, in comparison with sevoflurane, as assessed with 
SOMCT in 56 patients undergoing craniotomy. In their study, 
the mean body mass index values were 27.7 and 28.1 for des-
flurane and sevoflurane, whereas our study had essentially the 
same mean body mass index of 27.8 for both groups. We were 
unable to demonstrate any difference in recovery time to baseline 
SOMCT scores. Therefore, it is unlikely that the body habitus (and 
inhalational anesthetic retention) is the cause for the differences 
in cognitive impairment between the two studies. It is possible 
that the anesthetic duration that was nearly twice longer in their 
study and, presumably, the specific characteristics of the patient 
group undergoing craniotomy for resection of supratentorial 
lesions may have influenced the slower cognitive recovery in the 
sevoflurane group.
Other studies have utilized the mini-mental status exams 
(MMSE) and digit-symbol substitution tests to assess cognitive 
impairment, with multiple studies showing no difference in cog-
nitive impairment using these tests (2, 10, 12–14). Furthermore, 
the MMSE has been shown to have a sensitivity of 87%, a specific-
ity of 82%, and a false positive ratio of 39% when used to detect 
dementia and delirium on a general medicine floor (15). Based 
on the positive findings from Bilotta et al., we decided that the 
SOMCT would be a more practical test for assessing post-opera-
tive cognitive impairment on a timely basis. As with any test that 
is repeated over time, one is concerned with test–retest reliability 
and the practice effect, which could mask cognitive impairment 
(16). Our patient population included both middle-aged and 
elderly patients with a mean age of 61 years, so it is possible that 
observation of impairment was reduced secondarily to the inclu-
sion of relatively younger patients. Future studies are needed to 
validate the SOMCT for post-operative assessment of cognitive 
dysfunction in elderly patients (over 65 years) and compare its 
usefulness with other relevant neuropsychological tests.
Multiple researchers have studied airway irritation as a sec-
ondary outcome when comparing desflurane with sevoflurane. 
In a recently published study, the amount of premedication and 
opiates administered to patients had been limited with an attempt 
to expedite patient discharge and diminish post-operative nausea 
and vomiting (4). The authors investigated coughing at induction, 
during the surgery, and extubation and reported that although 
coughing at each phase was not different between desflurane and 
sevoflurane groups, the combined cumulative incidence was sig-
nificantly higher in the desflurane group. Our study confirmed the 
validity of their results showing a similar, statistically significant 
increase in the incidence of cumulative perioperative coughing in 
the desflurane group. It has been shown that administering opioid 
on induction can diminish the airway irritability associated with 
desflurane (16). All patients in our study received 1–2 μg/kg of 
fentanyl on induction, and although it diminished the initial air-
way irritation associated with desflurane, it did not reduce overall 
coughing observed in the perioperative period. Of note, patients 
in the sevoflurane group had a higher preoperative incidence of 
pain and the amount of opiates administered to this group was 
marginally significantly increased (p =  0.062), which may have 
influenced the cumulative incidence of coughing. Saros et  al. 
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probably incorporated the most efforts to diminish airway irrita-
tion with desflurane (3). Despite these, stridor was noted in 5/35 
patients receiving desflurane versus 1/35 patients that received 
sevoflurane for anesthesia maintenance using a LMA. In our study, 
one patient that was anesthetized with desflurane had a laryngo-
spasm and required management that deviated from our study 
protocol and thus was excluded from data analysis. A randomized 
prospective study with airway irritation as the primary outcome 
should be performed to more definitively address this question.
Our study design also utilized 1 MAC of inhalational anesthetic 
to ventilate patients prior to LMA insertion and kept the machine 
primed with gas by turning off fresh gas inflow and leaving the 
vaporizers turned on during the interval between masking, LMA 
insertion, and reattachment of the breathing circuit. Furthermore, 
we placed the patient on mechanical ventilation until they began 
spontaneous ventilation. By performing these steps, we ensured 
a consistent end-tidal anesthetic concentration throughout the 
induction period and prevented any potential sudden exposure 
of highly concentrated desflurane during the recovering period 
from induction to return of spontaneous ventilation. Due to the 
application of the aforementioned approach and use of fentanyl 
on induction, no difference was revealed between the two groups 
in incidence of coughing at induction. Although coughing at 
extubation itself was not significantly different between the two 
treatment arms, this is the phase in which most of the cough-
ing events were observed. Perhaps a future study could look at 
administering fentanyl again 15 min prior to extubation to help 
attenuate the irritability around extubation.
cOnclUsiOn
Our study confirmed that patients receiving desflurane had a 
faster emergence and met the criteria to be discharged from the 
PACU earlier; however, the total time spent in PACU was not 
different. No difference was found in time to return to baseline 
cognition between both groups; however, our study was not 
designed to address this question as a primary outcome. Lastly, 
desflurane caused more airway irritation than sevoflurane, 
despite the administration of fentanyl on induction and ensuring 
a consistent end-tidal anesthetic gas concentration during the 
induction period.
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